Cargando…
The impact of specific cytokine directed treatment on severe COVID-19
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422045/ https://www.ncbi.nlm.nih.gov/pubmed/34493799 http://dx.doi.org/10.1038/s41375-021-01411-1 |
| _version_ | 1783749206417080320 |
|---|---|
| author | Reuken, P. A. Rüthrich, M. M. Hochhaus, A. Hammersen, J. Bauer, M. La Rosée, P. La Rosée, F. Stallmach, A. |
| author_facet | Reuken, P. A. Rüthrich, M. M. Hochhaus, A. Hammersen, J. Bauer, M. La Rosée, P. La Rosée, F. Stallmach, A. |
| author_sort | Reuken, P. A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8422045 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84220452021-09-07 The impact of specific cytokine directed treatment on severe COVID-19 Reuken, P. A. Rüthrich, M. M. Hochhaus, A. Hammersen, J. Bauer, M. La Rosée, P. La Rosée, F. Stallmach, A. Leukemia Correspondence Nature Publishing Group UK 2021-09-07 2021 /pmc/articles/PMC8422045/ /pubmed/34493799 http://dx.doi.org/10.1038/s41375-021-01411-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Reuken, P. A. Rüthrich, M. M. Hochhaus, A. Hammersen, J. Bauer, M. La Rosée, P. La Rosée, F. Stallmach, A. The impact of specific cytokine directed treatment on severe COVID-19 |
| title | The impact of specific cytokine directed treatment on severe COVID-19 |
| title_full | The impact of specific cytokine directed treatment on severe COVID-19 |
| title_fullStr | The impact of specific cytokine directed treatment on severe COVID-19 |
| title_full_unstemmed | The impact of specific cytokine directed treatment on severe COVID-19 |
| title_short | The impact of specific cytokine directed treatment on severe COVID-19 |
| title_sort | impact of specific cytokine directed treatment on severe covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422045/ https://www.ncbi.nlm.nih.gov/pubmed/34493799 http://dx.doi.org/10.1038/s41375-021-01411-1 |
| work_keys_str_mv | AT reukenpa theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT ruthrichmm theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT hochhausa theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT hammersenj theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT bauerm theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT laroseep theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT laroseef theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT stallmacha theimpactofspecificcytokinedirectedtreatmentonseverecovid19 AT reukenpa impactofspecificcytokinedirectedtreatmentonseverecovid19 AT ruthrichmm impactofspecificcytokinedirectedtreatmentonseverecovid19 AT hochhausa impactofspecificcytokinedirectedtreatmentonseverecovid19 AT hammersenj impactofspecificcytokinedirectedtreatmentonseverecovid19 AT bauerm impactofspecificcytokinedirectedtreatmentonseverecovid19 AT laroseep impactofspecificcytokinedirectedtreatmentonseverecovid19 AT laroseef impactofspecificcytokinedirectedtreatmentonseverecovid19 AT stallmacha impactofspecificcytokinedirectedtreatmentonseverecovid19 |